RivierGKhamashtaMAHughesGR. Warfarin and azathioprine: A drug interaction does exist (letter). Am J Med1993;95: 342.
2.
SingletonJDConyersL. Warfarin and azathioprine: An important drug interaction (letter). Am J Med1992;92: 217.
3.
SpiersASMibashanRS. Increased warfarin requirement during mercaptopurine therapy: A new drug interaction (letter). Lancet1974;2: 221–2.
4.
TashimaCK. Cyclophosphamide effect on coumarin anticoagulation. South Med J1979;72: 633–4.
5.
CuddyPGLoftusLS. Influence of mitotane on the hypoprothrombinemic effect of warfarin. South Med J1986;79: 387–8.
6.
MartiniAJahnchenE. Studies in rats on the mechanism by which 6-mercaptopurine inhibits the anticoagulant effect of warfarin. J Pharmacol Exp Ther1977;201: 547–53.
7.
UdallJA. Clinical implications of warfarin interactions with five sedatives. Am J Cardiol1975;35: 67–71.
8.
HylekEMHeimanHSkatesSSheehanMASingerDE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA1998;279: 657–62.
9.
BartleWRBlakelyJA. Potentiation of warfarin anticoagulation by acetaminophen (letter). JAMA1991;265: 1260.
10.
VarmaTR. Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women. Int J Gynaecol Obstet1983;21: 291–6.
11.
NotelovitzMKitchensCWareMHirschbergKCooneL. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation. Obstet Gynecol1983;62: 596–600.
12.
DevorMBarrett-ConnorERenvallMFeigalDJrRamsdellJ. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med1992;92: 275–82.